Asia Pacific Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Antibody Therapeutics Market would witness market growth of 15.3 % CAGR during the forecast period (2023-2030).

Antibody therapeutics are used in treating hematological disorders. For example, Rituximab is utilized in certain types of leukemia and lymphoma by targeting B cells. Additionally, antibodies like Eculizumab can inhibit the complement system, providing a treatment option for disorders such as paroxysmal nocturnal hemoglobinuria (PNH). These are being explored in neurological disorders. In conditions like multiple sclerosis, monoclonal antibodies such as Natalizumab and Ocrelizumab target immune cells involved in the disease process. Antibodies may also be investigated for their potential in neurodegenerative disorders like Alzheimer's disease. Antibody therapeutics are being researched for applications in cardiovascular diseases. Targeting specific factors involved in atherosclerosis or thrombosis, antibodies aim to reduce the risk of cardiovascular events. For instance, Evolocumab and Alirocumab target PCSK9 to lower cholesterol levels.

Antibody therapeutics are explored in gynecological conditions. Bevacizumab, for example, is used to treat certain gynecological cancers by inhibiting angiogenesis. In the realm of rare diseases, antibody therapeutics offer targeted solutions. For example, Eculizumab treats PNH, a rare blood disorder. Furthermore, bispecific antibodies, designed to bind to two targets simultaneously, are gaining prominence. These antibodies offer innovative therapeutic strategies by engaging multiple pathways or cell types. Bispecific antibodies can redirect immune cells to tumor cells, enhance target binding, or modulate dual signaling pathways. Advancements in bispecific antibody engineering are expanding their applications across various diseases.

According to the National Library of Medicine, asthma is a significant public health issue in China, with a national prevalence of 4.2%, or 45.7 million Chinese adults. The prevalence of asthma has been increasing globally, including in China. A considerable proportion of asthma cases are attributable to China's large and expanding population, emphasizing the criticality of effective and targeted treatment options. The enlargement of asthma cases necessitates a healthcare infrastructure ready to adopt and integrate innovative therapies in China. Advances in antibody engineering have resulted in the development of long-acting formulations, allowing for less frequent dosing in China. All these factors will uplift the regional market’s expansion in the coming years.

The China market dominated the Asia Pacific Antibody Therapeutics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $47,019.6 million by 2030. The Japan market is showcasing a CAGR of 14.6% during (2023 - 2030). Additionally, The India market would register a CAGR of 16% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous, and Others. Based on Format, the market is segmented into Monoclonal Antibody, Polyclonal Antibody Therapy, Bispecific Antibody, Antibody fragment & Others. Based on Source, the market is segmented into Human, Humanized, and Chimeric. Based on End User, the market is segmented into Hospitals, Long-term care facilities, and Others. Based on Disease Areas, the market is segmented into Autoimmune & Inflammatory Diseases, Neurology, Osteology, Hematology, Oncology, Infectious Diseases, Immunology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Global Antibody Therapeutics Market is Predict to reach $631.3 Billion by 2030, at a CAGR of 14.4%

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd, AbbVie, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Merck KGaA, Bristol Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Novartis AG, Biogen, Inc. and Amgen, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration

• Intravenous
• Subcutaneous
• Others

By Format

• Monoclonal Antibody
• Polyclonal Antibody Therapy
• Bispecific Antibody
• Antibody fragment & Others

By Source

• Human
• Humanized
• Chimeric

By End User

• Hospitals
• Long-term care facilities
• Other

By Disease Areas

• Autoimmune & Inflammatory Diseases
• Neurology
• Osteology
• Hematology
• Oncology
• Infectious Diseases
• Immunology
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• F.Hoffmann-La Roche Ltd
• AbbVie, Inc.
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• Merck KGaA
• Bristol Myers Squibb Company
• AstraZeneca PLC
• Sanofi S.A.
• Novartis AG
• Biogen, Inc.
• Amgen, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antibody Therapeutics Market, by Route of Administration
1.4.2 Asia Pacific Antibody Therapeutics Market, by Format
1.4.3 Asia Pacific Antibody Therapeutics Market, by Source
1.4.4 Asia Pacific Antibody Therapeutics Market, by End User
1.4.5 Asia Pacific Antibody Therapeutics Market, by Disease Areas
1.4.6 Asia Pacific Antibody Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Antibody Therapeutics market.

Chapter 5. Asia Pacific Antibody Therapeutics Market by Route of Administration
5.1 Asia Pacific Intravenous Market by Country
5.2 Asia Pacific Subcutaneous Market by Country
5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Antibody Therapeutics Market by Format
6.1 Asia Pacific Monoclonal Antibody Market by Country
6.2 Asia Pacific Polyclonal Antibody Therapy Market by Country
6.3 Asia Pacific Bispecific Antibody Market by Country
6.4 Asia Pacific Antibody fragment & Others Market by Country

Chapter 7. Asia Pacific Antibody Therapeutics Market by Source
7.1 Asia Pacific Human Market by Country
7.2 Asia Pacific Humanized Market by Country
7.3 Asia Pacific Chimeric Market by Country
7.4 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Antibody Therapeutics Market by End User
8.1 Asia Pacific Hospitals Market by Country
8.2 Asia Pacific Long-term care facilities Market by Country
8.3 Asia Pacific Others Market by Country

Chapter 9. Asia Pacific Antibody Therapeutics Market by Disease Areas
9.1 Asia Pacific Autoimmune & Inflammatory Diseases Market by Country
9.2 Asia Pacific Neurology Market by Country
9.3 Asia Pacific Osteology Market by Country
9.4 Asia Pacific Hematology Market by Country
9.5 Asia Pacific Oncology Market by Country
9.6 Asia Pacific Infectious Diseases Market by Country
9.7 Asia Pacific Immunology Market by Country
9.8 Asia Pacific Others Market by Country

Chapter 10. Asia Pacific Antibody Therapeutics Market by Country
10.1 China Antibody Therapeutics Market
10.1.1 China Antibody Therapeutics Market by Route of Administration
10.1.2 China Antibody Therapeutics Market by Format
10.1.3 China Antibody Therapeutics Market by Source
10.1.4 China Antibody Therapeutics Market by End User
10.1.5 China Antibody Therapeutics Market by Disease Areas
10.2 Japan Antibody Therapeutics Market
10.2.1 Japan Antibody Therapeutics Market by Route of Administration
10.2.2 Japan Antibody Therapeutics Market by Format
10.2.3 Japan Antibody Therapeutics Market by Source
10.2.4 Japan Antibody Therapeutics Market by End User
10.2.5 Japan Antibody Therapeutics Market by Disease Areas
10.3 India Antibody Therapeutics Market
10.3.1 India Antibody Therapeutics Market by Route of Administration
10.3.2 India Antibody Therapeutics Market by Format
10.3.3 India Antibody Therapeutics Market by Source
10.3.4 India Antibody Therapeutics Market by End User
10.3.5 India Antibody Therapeutics Market by Disease Areas
10.4 South Korea Antibody Therapeutics Market
10.4.1 South Korea Antibody Therapeutics Market by Route of Administration
10.4.2 South Korea Antibody Therapeutics Market by Format
10.4.3 South Korea Antibody Therapeutics Market by Source
10.4.4 South Korea Antibody Therapeutics Market by End User
10.4.5 South Korea Antibody Therapeutics Market by Disease Areas
10.5 Singapore Antibody Therapeutics Market
10.5.1 Singapore Antibody Therapeutics Market by Route of Administration
10.5.2 Singapore Antibody Therapeutics Market by Format
10.5.3 Singapore Antibody Therapeutics Market by Source
10.5.4 Singapore Antibody Therapeutics Market by End User
10.5.5 Singapore Antibody Therapeutics Market by Disease Areas
10.6 Malaysia Antibody Therapeutics Market
10.6.1 Malaysia Antibody Therapeutics Market by Route of Administration
10.6.2 Malaysia Antibody Therapeutics Market by Format
10.6.3 Malaysia Antibody Therapeutics Market by Source
10.6.4 Malaysia Antibody Therapeutics Market by End User
10.6.5 Malaysia Antibody Therapeutics Market by Disease Areas
10.7 Rest of Asia Pacific Antibody Therapeutics Market
10.7.1 Rest of Asia Pacific Antibody Therapeutics Market by Route of Administration
10.7.2 Rest of Asia Pacific Antibody Therapeutics Market by Format
10.7.3 Rest of Asia Pacific Antibody Therapeutics Market by Source
10.7.4 Rest of Asia Pacific Antibody Therapeutics Market by End User
10.7.5 Rest of Asia Pacific Antibody Therapeutics Market by Disease Areas

Chapter 11. Company Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Acquisition and Mergers:
11.2.6 SWOT Analysis
11.3 Johnson & Johnson (Johnson & Johnson Services, Inc.)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental &Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.6 SWOT Analysis
11.4 Merck KGaA
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.6 SWOT Analysis
11.5 Bristol Myers Squibb Company
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Regional Analysis
11.5.4 Research & Development Expenses
11.5.5 Recent strategies and developments:
11.5.5.1 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 AstraZeneca PLC
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 SWOT Analysis
11.7 Sanofi S.A.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 SWOT Analysis
11.8 Novartis AG
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expense
11.8.5 SWOT Analysis
11.9 Biogen, Inc.
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. Amgen, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 SWOT Analysis

TABLE 1 Asia Pacific Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Intravenous Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Intravenous Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Subcutaneous Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Subcutaneous Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Monoclonal Antibody Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Monoclonal Antibody Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Polyclonal Antibody Therapy Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Polyclonal Antibody Therapy Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Bispecific Antibody Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Bispecific Antibody Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Antibody fragment & Others Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Antibody fragment & Others Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Human Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Human Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Humanized Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Humanized Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Chimeric Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Chimeric Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 33 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 35 Asia Pacific Long-term care facilities Market by Country, 2019 - 2022, USD Million
TABLE 36 Asia Pacific Long-term care facilities Market by Country, 2023 - 2030, USD Million
TABLE 37 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 38 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 39 Asia Pacific Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 40 Asia Pacific Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 41 Asia Pacific Autoimmune & Inflammatory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 42 Asia Pacific Autoimmune & Inflammatory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 43 Asia Pacific Neurology Market by Country, 2019 - 2022, USD Million
TABLE 44 Asia Pacific Neurology Market by Country, 2023 - 2030, USD Million
TABLE 45 Asia Pacific Osteology Market by Country, 2019 - 2022, USD Million
TABLE 46 Asia Pacific Osteology Market by Country, 2023 - 2030, USD Million
TABLE 47 Asia Pacific Hematology Market by Country, 2019 - 2022, USD Million
TABLE 48 Asia Pacific Hematology Market by Country, 2023 - 2030, USD Million
TABLE 49 Asia Pacific Oncology Market by Country, 2019 - 2022, USD Million
TABLE 50 Asia Pacific Oncology Market by Country, 2023 - 2030, USD Million
TABLE 51 Asia Pacific Infectious Diseases Market by Country, 2019 - 2022, USD Million
TABLE 52 Asia Pacific Infectious Diseases Market by Country, 2023 - 2030, USD Million
TABLE 53 Asia Pacific Immunology Market by Country, 2019 - 2022, USD Million
TABLE 54 Asia Pacific Immunology Market by Country, 2023 - 2030, USD Million
TABLE 55 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 56 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 57 Asia Pacific Antibody Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 58 Asia Pacific Antibody Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 59 China Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 60 China Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 61 China Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 62 China Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 63 China Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 64 China Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 65 China Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 66 China Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 67 China Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 68 China Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 69 China Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 70 China Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 71 Japan Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 72 Japan Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 73 Japan Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 74 Japan Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 75 Japan Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 76 Japan Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 77 Japan Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 78 Japan Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 79 Japan Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 80 Japan Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 81 Japan Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 82 Japan Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 83 India Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 84 India Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 85 India Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 India Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 India Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 88 India Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 89 India Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 90 India Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 91 India Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 92 India Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 93 India Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 94 India Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 95 South Korea Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 96 South Korea Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 97 South Korea Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 98 South Korea Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 99 South Korea Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 100 South Korea Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 101 South Korea Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 102 South Korea Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 103 South Korea Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 104 South Korea Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 105 South Korea Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 106 South Korea Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 107 Singapore Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 108 Singapore Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 109 Singapore Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 110 Singapore Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 111 Singapore Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 112 Singapore Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 113 Singapore Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 114 Singapore Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 115 Singapore Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 116 Singapore Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 117 Singapore Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 118 Singapore Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 119 Malaysia Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 120 Malaysia Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 121 Malaysia Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 122 Malaysia Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 123 Malaysia Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 124 Malaysia Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 125 Malaysia Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 126 Malaysia Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 127 Malaysia Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 128 Malaysia Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 129 Malaysia Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 130 Malaysia Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 131 Rest of Asia Pacific Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 132 Rest of Asia Pacific Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 133 Rest of Asia Pacific Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 Rest of Asia Pacific Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 135 Rest of Asia Pacific Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 136 Rest of Asia Pacific Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 137 Rest of Asia Pacific Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 138 Rest of Asia Pacific Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 139 Rest of Asia Pacific Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 140 Rest of Asia Pacific Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 141 Rest of Asia Pacific Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 142 Rest of Asia Pacific Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 143 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 144 Key information – AbbVie, Inc.
TABLE 145 Key Information – Johnson & Johnson
TABLE 146 key Information – Merck KGaA
TABLE 147 Key Information – Bristol Myers Squibb Company
TABLE 148 KEY INFORMATION – AstraZeneca PLC
TABLE 149 Key Information – Sanofi S.A.
TABLE 150 Key Information – Novartis AG
TABLE 151 Key Information – Biogen, Inc.
TABLE 152 Key Information – Amgen, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Antibody Therapeutics Market, 2019- 2030, USD Million
FIG 3 Porter’s Five Forces Analysis – Antibody Therapeutics Market
FIG 4 Key Factors Impacting Antibody Therapeutics Market
FIG 5 Asia Pacific Antibody Therapeutics Market share by Route of Administration, 2022
FIG 6 Asia Pacific Antibody Therapeutics Market share by Route of Administration, 2030
FIG 7 Asia Pacific Antibody Therapeutics Market by Route of Administration, 2019 - 2030, USD Million
FIG 8 Asia Pacific Antibody Therapeutics Market share by Format, 2022
FIG 9 Asia Pacific Antibody Therapeutics Market share by Format, 2030
FIG 10 Asia Pacific Antibody Therapeutics Market by Format, 2019 - 2030, USD Million
FIG 11 Asia Pacific Antibody Therapeutics Market share by Source, 2022
FIG 12 Asia Pacific Antibody Therapeutics Market share by Source, 2030
FIG 13 Asia Pacific Antibody Therapeutics Market by Source, 2019 - 2030, USD Million
FIG 14 Asia Pacific Antibody Therapeutics Market share by End User, 2022
FIG 15 Asia Pacific Antibody Therapeutics Market share by End User, 2030
FIG 16 Asia Pacific Antibody Therapeutics Market by End User, 2019 - 2030, USD Million
FIG 17 Asia Pacific Antibody Therapeutics Market share by Disease Areas, 2022
FIG 18 Asia Pacific Antibody Therapeutics Market share by Disease Areas, 2030
FIG 19 Asia Pacific Antibody Therapeutics Market by Disease Areas, 2019 - 2030, USD Million
FIG 20 Asia Pacific Antibody Therapeutics Market share by Country, 2022
FIG 21 Asia Pacific Antibody Therapeutics Market share by Country, 2030
FIG 22 Asia Pacific Antibody Therapeutics Market by Country, 2019 - 2030, USD Million
FIG 23 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 25 Recent strategies and developments: AbbVie, Inc.
FIG 26 Swot Analysis: AbbVie, Inc.
FIG 27 Swot Analysis: Johnson & Johnson
FIG 28 Swot Analysis: Merck KGaA
FIG 29 SWOT Analysis: Bristol Myers Squibb Company
FIG 30 SWOT Analysis: AstraZeneca PLC
FIG 31 Swot Analysis: Sanofi S.A.
FIG 32 SWOT Analysis: Novartis AG
FIG 33 SWOT Analysis: Biogen, Inc.
FIG 34 Swot Analysis: Amgen, Inc.